Evidence map›Paper›PMID 40885498›Full record

ArticleBrain, behavior, and immunity2025

Active coping mitigates the effects of stress on glucocorticoid levels in the prefrontal cortex.

Matthew G Frank, Emily S Levy, Gianni N Bonnici, Steven F Maier, Michael V Baratta

Abstract read
In one paragraph

Article in Brain, behavior, and immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Matthew G FrankDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO 80301, USA; Department of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80301, USA. Electronic address: matt.frank@colorado.edu.
Emily S LevyDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO 80301, USA.
Gianni N BonniciDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO 80301, USA.
Steven F MaierDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO 80301, USA.
Michael V BarattaDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO 80301, USA.

Funding

Stressor Controllability: The Role of the mPFC in Producing ResiliencyR01MH050479 · NIMH · UNIVERSITY OF COLORADO AT BOULDER · PI MICHAEL V BARATTA, STEVEN F MAIER · 1993 to 2026
$7.9M
NIMH NIH HHS R01 MH050479
6 · The paper itself

Abstract

Exposure to stressors elevates glucocorticoid (GC) levels in the periphery and brain, directly impacting neurogenesis, neuronal morphology and function, as well as neuroinflammatory processes. The ability to exert behavioral control over an adverse event prevents many of the sequelae of stressor exposure; however, extensive evidence indicates that this protection occurs without concomitant reductions in hypothalamic-pituitary-adrenal (HPA) axis activity. Given that brain GC levels can be regulated independently of changes in HPA output, we investigated whether controllability might alter corticosterone (CORT) levels and CORT-sensitive gene expression in rat brain, even though it does not modulate peripheral CORT. We found that behavioral control (escapable shock, ES) selectively attenuated stress-induced CORT and modulated CORT-sensitive genes (Nr3c1, Ilb, Nlrp3, and Cd200r1), as well as IL-1β protein in the medial prefrontal cortex (PFC) relative to uncontrollable stress (inescapable shock, IS). Stress-induced expression of PFC 11β-hydroxysteroid dehydrogenase type 1, an enzyme that regulates local concentrations of CORT, was increased (mRNA) and decreased (protein) in ES relative to IS. These controllability effects were absent in other brain structures previously implicated in the differential behavioral outcomes of ES and IS. Together, the findings provide initial evidence that active coping with a stressor is a key determinant for regulating GC action, potentially shaping cognitive and neuroimmune responses to adverse events at a local tissue level.

Indexed as

Adaptation, PsychologicalGlucocorticoidsPrefrontal CortexStress, PsychologicalAnimalsCorticosteroneHypothalamo-Hypophyseal SystemInterleukin-1betaMalePituitary-Adrenal SystemRatsRats, Sprague-DawleyReceptors, GlucocorticoidCorticosteroneGlucocorticoidsInterleukin-1betaReceptors, GlucocorticoidControllabilityCopingCortexCorticosteroneGlucocorticoidNeuroinflammationPrefrontalPrimingStressor

Identifiers

PMID40885498
PMCPMC12593236

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.